ISAB

International Supervisory and Advisory Board (ISAB)

• Prof. Adriana Albini, Università degli Studi di Milano-Bicocca, Italy
• Prof. Daniela Elena Costea, Universitetet i Bergen, Norway
• Dr. Asta Försti, Deutsches Krebsforschungszentrum, Heidelberg, Germany
• Prof. Jochen Hampe, Universitätsklinikum Carl Gustav Carus Dresden, Germany
• Prof. Richard Houlston, Institute of Cancer Research, London, Great Britain
• Prof. Jindřich Kopeček, University of Utah, USA
• Prof. Viktor Umansky, Deutsches Krebsforschungszentrum, Heidelberg, Germany
• Assoc. Prof. Britta Will, Albert Einstein College of Medicine, USA
• Dr. Petr Kocis, AstraZeneca, currently an independent consultant
• Dr. Jakub Hlávka, economist, University of Southern California, USA
• Assoc. Prof. Pavel Koukal, Faculty of Law, Masaryk University, Brno, Czech Republic
• Prof. Petr Jarolím, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, USA.